Background
The question of anticoagulant dosing in hospitalized patients with coronavirus disease-2019 (COVID-19) is unresolved, with randomized trials showing mixed results and heterogeneity of treatment effects for in-hospital death.
Objective
To examine the association between the intensity of anticoagulation and clinical outcomes in hospitalized patients with COVID-19.